Transformation of intestinal epithelial cells by chronic TGF-β1 treatment results in downregulation of the type II TGF-β receptor and induction ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

1999-01-28

AUTHORS

Hongmiao Sheng, Jinyi Shao, Christine A O'Mahony, Laura Lamps, Daniel Albo, Peter C Isakson, David H Berger, Raymond N DuBois, R Daniel Beauchamp

ABSTRACT

The precise role of TGF-β in colorectal carcinogenesis is not clear. The purpose of this study was to determine the phenotypic alterations caused by chronic exposure to TGF-β in non-transformed intestinal epithelial (RIE-1) cells. Growth of RIE-1 cells was inhibited by >75% following TGF-β1 treatment for 7 days, after which the cells resumed a normal growth despite the presence of TGF-β1. These `TGF-β-resistant' cells (RIE-Tr) were continuously exposed to TGF-β for >50 days. Unlike the parental RIE cells, RIE-Tr cells lost contact inhibition, formed foci in culture, grew in soft agarose. RIE-Tr cells demonstrated TGF-β-dependent invasive potential in an in vitro assay and were resistant to Matrigel and Na-butyrate-induced apoptosis. The RIE-Tr cells were also tumorigenic in nude mice. The transformed phenotype of RIE-Tr cells was associated with a 95% decrease in the level of the type II TGF-β receptor (TβRII) protein, a 40-fold increase in cyclooxygenase-2 (COX-2) protein, and 5.9-fold increase in the production of prostacyclin. Most RIE-Tr subclones that expressed low levels of TβRII and high levels of COX-2 were tumorigenic. Those subclones that express abundant TβRII and low levels of COX-2 were not tumorigenic in nude mice. A selective COX-2 inhibitor inhibited RIE-Tr cell growth in culture and tumor growth in nude mice. The reduced expression of TβRII, increased expression of COX-2, and the ability to form colonies in Matrigel were all reversible upon withdrawal of exogenous TGF-β1 for the RIE-Tr cells. More... »

PAGES

855-867

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.onc.1202397

DOI

http://dx.doi.org/10.1038/sj.onc.1202397

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1011970400

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/10023661


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Apoptosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Count", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Division", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Transformation, Neoplastic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclooxygenase 2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Down-Regulation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Resistance", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Enzyme Induction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Epithelial Cells", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Intestines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Isoenzymes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phenotype", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prostaglandin-Endoperoxide Synthases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein Serine-Threonine Kinases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptor, Transforming Growth Factor-beta Type II", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptors, Transforming Growth Factor beta", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transforming Growth Factor beta", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Surgery, The Vanderbilt Cancer Center, Vanderbilt University Medical Center, and VA Medical Center, 37232, Nashville, Tennessee, USA", 
          "id": "http://www.grid.ac/institutes/grid.412807.8", 
          "name": [
            "Department of Surgery, The Vanderbilt Cancer Center, Vanderbilt University Medical Center, and VA Medical Center, 37232, Nashville, Tennessee, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sheng", 
        "givenName": "Hongmiao", 
        "id": "sg:person.01305166203.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01305166203.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, The Vanderbilt Cancer Center, Vanderbilt University Medical Center, and VA Medical Center, 37232, Nashville, Tennessee, USA", 
          "id": "http://www.grid.ac/institutes/grid.412807.8", 
          "name": [
            "Department of Surgery, The Vanderbilt Cancer Center, Vanderbilt University Medical Center, and VA Medical Center, 37232, Nashville, Tennessee, USA", 
            "Department of Medicine, The Vanderbilt Cancer Center, Vanderbilt University Medical Center, and VA Medical Center, 37232, Nashville, Tennessee, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shao", 
        "givenName": "Jinyi", 
        "id": "sg:person.01063521507.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01063521507.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Allegheny University of the Health Sciences, Philadelphia, Pennsylvania, USA", 
          "id": "http://www.grid.ac/institutes/grid.166341.7", 
          "name": [
            "Department of Surgery, Allegheny University of the Health Sciences, Philadelphia, Pennsylvania, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "O'Mahony", 
        "givenName": "Christine A", 
        "id": "sg:person.01323503556.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01323503556.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, The Vanderbilt Cancer Center, Vanderbilt University Medical Center, and VA Medical Center, 37232, Nashville, Tennessee, USA", 
          "id": "http://www.grid.ac/institutes/grid.412807.8", 
          "name": [
            "Department of Pathology, The Vanderbilt Cancer Center, Vanderbilt University Medical Center, and VA Medical Center, 37232, Nashville, Tennessee, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lamps", 
        "givenName": "Laura", 
        "id": "sg:person.013355461651.60", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013355461651.60"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Allegheny University of the Health Sciences, Philadelphia, Pennsylvania, USA", 
          "id": "http://www.grid.ac/institutes/grid.166341.7", 
          "name": [
            "Department of Surgery, Allegheny University of the Health Sciences, Philadelphia, Pennsylvania, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Albo", 
        "givenName": "Daniel", 
        "id": "sg:person.01235552457.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235552457.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "63198, USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Inflammatory Disease Research, Searle R & D, St Louis, Missouri", 
            "63198, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Isakson", 
        "givenName": "Peter C", 
        "id": "sg:person.01253543620.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01253543620.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Allegheny University of the Health Sciences, Philadelphia, Pennsylvania, USA", 
          "id": "http://www.grid.ac/institutes/grid.166341.7", 
          "name": [
            "Department of Surgery, Allegheny University of the Health Sciences, Philadelphia, Pennsylvania, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Berger", 
        "givenName": "David H", 
        "id": "sg:person.01153613737.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01153613737.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cell Biology, The Vanderbilt Cancer Center, Vanderbilt University Medical Center, and VA Medical Center, 37232, Nashville, Tennessee, USA", 
          "id": "http://www.grid.ac/institutes/grid.412807.8", 
          "name": [
            "Department of Medicine, The Vanderbilt Cancer Center, Vanderbilt University Medical Center, and VA Medical Center, 37232, Nashville, Tennessee, USA", 
            "Department of Cell Biology, The Vanderbilt Cancer Center, Vanderbilt University Medical Center, and VA Medical Center, 37232, Nashville, Tennessee, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "DuBois", 
        "givenName": "Raymond N", 
        "id": "sg:person.0626301614.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0626301614.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cell Biology, The Vanderbilt Cancer Center, Vanderbilt University Medical Center, and VA Medical Center, 37232, Nashville, Tennessee, USA", 
          "id": "http://www.grid.ac/institutes/grid.412807.8", 
          "name": [
            "Department of Surgery, The Vanderbilt Cancer Center, Vanderbilt University Medical Center, and VA Medical Center, 37232, Nashville, Tennessee, USA", 
            "Department of Cell Biology, The Vanderbilt Cancer Center, Vanderbilt University Medical Center, and VA Medical Center, 37232, Nashville, Tennessee, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Beauchamp", 
        "givenName": "R Daniel", 
        "id": "sg:person.01355254152.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01355254152.34"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/383691a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031722017", 
          "https://doi.org/10.1038/383691a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/382386a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003505430", 
          "https://doi.org/10.1038/382386a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1201902", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000680860", 
          "https://doi.org/10.1038/sj.onc.1201902"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1999-01-28", 
    "datePublishedReg": "1999-01-28", 
    "description": "The precise role of TGF-\u03b2 in colorectal carcinogenesis is not clear. The purpose of this study was to determine the phenotypic alterations caused by chronic exposure to TGF-\u03b2 in non-transformed intestinal epithelial (RIE-1) cells. Growth of RIE-1 cells was inhibited by >75% following TGF-\u03b21 treatment for 7 days, after which the cells resumed a normal growth despite the presence of TGF-\u03b21. These `TGF-\u03b2-resistant' cells (RIE-Tr) were continuously exposed to TGF-\u03b2 for >50 days. Unlike the parental RIE cells, RIE-Tr cells lost contact inhibition, formed foci in culture, grew in soft agarose. RIE-Tr cells demonstrated TGF-\u03b2-dependent invasive potential in an in vitro assay and were resistant to Matrigel and Na-butyrate-induced apoptosis. The RIE-Tr cells were also tumorigenic in nude mice. The transformed phenotype of RIE-Tr cells was associated with a 95% decrease in the level of the type II TGF-\u03b2 receptor (T\u03b2RII) protein, a 40-fold increase in cyclooxygenase-2 (COX-2) protein, and 5.9-fold increase in the production of prostacyclin. Most RIE-Tr subclones that expressed low levels of T\u03b2RII and high levels of COX-2 were tumorigenic. Those subclones that express abundant T\u03b2RII and low levels of COX-2 were not tumorigenic in nude mice. A selective COX-2 inhibitor inhibited RIE-Tr cell growth in culture and tumor growth in nude mice. The reduced expression of T\u03b2RII, increased expression of COX-2, and the ability to form colonies in Matrigel were all reversible upon withdrawal of exogenous TGF-\u03b21 for the RIE-Tr cells.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/sj.onc.1202397", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2495856", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2472568", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2495079", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2438863", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2408854", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1097543", 
        "issn": [
          "0950-9232", 
          "1476-5594"
        ], 
        "name": "Oncogene", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "18"
      }
    ], 
    "keywords": [
      "COX-2", 
      "intestinal epithelial cells", 
      "nude mice", 
      "TGF-\u03b21", 
      "selective COX-2 inhibitors", 
      "epithelial cells", 
      "cyclooxygenase-2 protein", 
      "production of prostacyclin", 
      "COX-2 inhibitors", 
      "TGF-\u03b21 treatment", 
      "type II TGF-\u03b2 receptor", 
      "exogenous TGF-\u03b21", 
      "TGF-\u03b2 receptor", 
      "non-transformed intestinal epithelial cells", 
      "cyclooxygenase-2", 
      "RIE-1 cells", 
      "colorectal carcinogenesis", 
      "chronic exposure", 
      "tumor growth", 
      "treatment results", 
      "RIE cells", 
      "TGF", 
      "low levels", 
      "reduced expression", 
      "mice", 
      "soft agarose", 
      "T\u03b2RII", 
      "precise role", 
      "invasive potential", 
      "receptor protein", 
      "phenotypic alterations", 
      "cell growth", 
      "cells", 
      "normal growth", 
      "contact inhibition", 
      "Matrigel", 
      "days", 
      "high levels", 
      "prostacyclin", 
      "levels", 
      "expression", 
      "subclones", 
      "carcinogenesis", 
      "receptors", 
      "downregulation", 
      "treatment", 
      "withdrawal", 
      "apoptosis", 
      "inhibitors", 
      "inhibition", 
      "protein", 
      "alterations", 
      "exposure", 
      "induction", 
      "increase", 
      "phenotype", 
      "assays", 
      "culture", 
      "decrease", 
      "study", 
      "role", 
      "growth", 
      "presence", 
      "purpose", 
      "ability", 
      "potential", 
      "agarose", 
      "focus", 
      "production", 
      "colonies", 
      "results", 
      "transformation"
    ], 
    "name": "Transformation of intestinal epithelial cells by chronic TGF-\u03b21 treatment results in downregulation of the type II TGF-\u03b2 receptor and induction of cyclooxygenase-2", 
    "pagination": "855-867", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1011970400"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.onc.1202397"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "10023661"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.onc.1202397", 
      "https://app.dimensions.ai/details/publication/pub.1011970400"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-20T07:21", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_329.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/sj.onc.1202397"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.onc.1202397'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.onc.1202397'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.onc.1202397'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.onc.1202397'


 

This table displays all metadata directly associated to this object as RDF triples.

301 TRIPLES      22 PREDICATES      120 URIs      109 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.onc.1202397 schema:about N01b7dd4289554a96acf8426f42f10b5d
2 N074fff7a4e254ca5b809db1ab221d05b
3 N0ca9e77a25664b36bdc8dc0bacdf6f1c
4 N136daa6f38904a8780a34fa9eb13abfb
5 N1f36787d7ded424fb0c8467dd5d19691
6 N24d067fcdc5347c58cf8363dfa46e96d
7 N25673e5412a34f8f894da17333179449
8 N2cd60967f3284c0e8ccb2c3d4b95d7ad
9 N3e15b3bee2cb4c169fb267fbfb3a6203
10 N49a6fa26312a4811b0f507e2645b1cdb
11 N52cafe5697f04075bf8d52df2d399203
12 N5f141eaf2a5c4819b38a15b39d41cb4a
13 N656ac46baa5247aeb5aafb78aeea1b27
14 N7e8a7628a1ad4dd299386df70026a600
15 Nd11c948e43f14fbf9ecd7bb286468d90
16 Ne07584b69f1e4e639187392961357ed7
17 Nef447d0ada49433ab732172836b34fb3
18 Nefdf3cb21e12468ea05b6193caef4c6e
19 Nfc3ce6eae5d2423eb1d6b4a8b80f11ac
20 anzsrc-for:11
21 anzsrc-for:1103
22 schema:author N7ffeb53f21644e4da2c739d64f410024
23 schema:citation sg:pub.10.1038/382386a0
24 sg:pub.10.1038/383691a0
25 sg:pub.10.1038/sj.onc.1201902
26 schema:datePublished 1999-01-28
27 schema:datePublishedReg 1999-01-28
28 schema:description The precise role of TGF-β in colorectal carcinogenesis is not clear. The purpose of this study was to determine the phenotypic alterations caused by chronic exposure to TGF-β in non-transformed intestinal epithelial (RIE-1) cells. Growth of RIE-1 cells was inhibited by >75% following TGF-β1 treatment for 7 days, after which the cells resumed a normal growth despite the presence of TGF-β1. These `TGF-β-resistant' cells (RIE-Tr) were continuously exposed to TGF-β for >50 days. Unlike the parental RIE cells, RIE-Tr cells lost contact inhibition, formed foci in culture, grew in soft agarose. RIE-Tr cells demonstrated TGF-β-dependent invasive potential in an in vitro assay and were resistant to Matrigel and Na-butyrate-induced apoptosis. The RIE-Tr cells were also tumorigenic in nude mice. The transformed phenotype of RIE-Tr cells was associated with a 95% decrease in the level of the type II TGF-β receptor (TβRII) protein, a 40-fold increase in cyclooxygenase-2 (COX-2) protein, and 5.9-fold increase in the production of prostacyclin. Most RIE-Tr subclones that expressed low levels of TβRII and high levels of COX-2 were tumorigenic. Those subclones that express abundant TβRII and low levels of COX-2 were not tumorigenic in nude mice. A selective COX-2 inhibitor inhibited RIE-Tr cell growth in culture and tumor growth in nude mice. The reduced expression of TβRII, increased expression of COX-2, and the ability to form colonies in Matrigel were all reversible upon withdrawal of exogenous TGF-β1 for the RIE-Tr cells.
29 schema:genre article
30 schema:inLanguage en
31 schema:isAccessibleForFree true
32 schema:isPartOf N9972f0565de74566addbda1e0ec2f6d1
33 Ne5b9540a9e024248b746eb744e7d8cce
34 sg:journal.1097543
35 schema:keywords COX-2
36 COX-2 inhibitors
37 Matrigel
38 RIE cells
39 RIE-1 cells
40 TGF
41 TGF-β receptor
42 TGF-β1
43 TGF-β1 treatment
44 TβRII
45 ability
46 agarose
47 alterations
48 apoptosis
49 assays
50 carcinogenesis
51 cell growth
52 cells
53 chronic exposure
54 colonies
55 colorectal carcinogenesis
56 contact inhibition
57 culture
58 cyclooxygenase-2
59 cyclooxygenase-2 protein
60 days
61 decrease
62 downregulation
63 epithelial cells
64 exogenous TGF-β1
65 exposure
66 expression
67 focus
68 growth
69 high levels
70 increase
71 induction
72 inhibition
73 inhibitors
74 intestinal epithelial cells
75 invasive potential
76 levels
77 low levels
78 mice
79 non-transformed intestinal epithelial cells
80 normal growth
81 nude mice
82 phenotype
83 phenotypic alterations
84 potential
85 precise role
86 presence
87 production
88 production of prostacyclin
89 prostacyclin
90 protein
91 purpose
92 receptor protein
93 receptors
94 reduced expression
95 results
96 role
97 selective COX-2 inhibitors
98 soft agarose
99 study
100 subclones
101 transformation
102 treatment
103 treatment results
104 tumor growth
105 type II TGF-β receptor
106 withdrawal
107 schema:name Transformation of intestinal epithelial cells by chronic TGF-β1 treatment results in downregulation of the type II TGF-β receptor and induction of cyclooxygenase-2
108 schema:pagination 855-867
109 schema:productId Nc09e045094d0438baca0554b59063afc
110 Nc89717951396402bb70dea36b29ffb2c
111 Nf7c31786ef9a4d6388791413cc1c5825
112 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011970400
113 https://doi.org/10.1038/sj.onc.1202397
114 schema:sdDatePublished 2022-05-20T07:21
115 schema:sdLicense https://scigraph.springernature.com/explorer/license/
116 schema:sdPublisher Nafedb1d3947b4ae389cb712bd3f0f3d9
117 schema:url https://doi.org/10.1038/sj.onc.1202397
118 sgo:license sg:explorer/license/
119 sgo:sdDataset articles
120 rdf:type schema:ScholarlyArticle
121 N01b7dd4289554a96acf8426f42f10b5d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Receptor, Transforming Growth Factor-beta Type II
123 rdf:type schema:DefinedTerm
124 N074fff7a4e254ca5b809db1ab221d05b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Cyclooxygenase 2
126 rdf:type schema:DefinedTerm
127 N0ca9e77a25664b36bdc8dc0bacdf6f1c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Drug Resistance
129 rdf:type schema:DefinedTerm
130 N110c41b3eb41438ab7f01586e574f1fd rdf:first sg:person.01063521507.06
131 rdf:rest N5ef842d444de45028cf95bd97cf32d9c
132 N136daa6f38904a8780a34fa9eb13abfb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Epithelial Cells
134 rdf:type schema:DefinedTerm
135 N15f1ee5b2d044341a45530503a1c7e01 rdf:first sg:person.01253543620.23
136 rdf:rest Nf532df598e3e49fb951fe4e9c1afa441
137 N1f36787d7ded424fb0c8467dd5d19691 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Cell Count
139 rdf:type schema:DefinedTerm
140 N24d067fcdc5347c58cf8363dfa46e96d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Prostaglandin-Endoperoxide Synthases
142 rdf:type schema:DefinedTerm
143 N25673e5412a34f8f894da17333179449 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Rats
145 rdf:type schema:DefinedTerm
146 N2cd60967f3284c0e8ccb2c3d4b95d7ad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Protein Serine-Threonine Kinases
148 rdf:type schema:DefinedTerm
149 N3e15b3bee2cb4c169fb267fbfb3a6203 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Apoptosis
151 rdf:type schema:DefinedTerm
152 N49a6fa26312a4811b0f507e2645b1cdb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Phenotype
154 rdf:type schema:DefinedTerm
155 N52cafe5697f04075bf8d52df2d399203 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Receptors, Transforming Growth Factor beta
157 rdf:type schema:DefinedTerm
158 N5ef842d444de45028cf95bd97cf32d9c rdf:first sg:person.01323503556.25
159 rdf:rest Nae455434f55248dd96124628bc4085a1
160 N5f141eaf2a5c4819b38a15b39d41cb4a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Isoenzymes
162 rdf:type schema:DefinedTerm
163 N656ac46baa5247aeb5aafb78aeea1b27 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Transforming Growth Factor beta
165 rdf:type schema:DefinedTerm
166 N7e8a7628a1ad4dd299386df70026a600 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Cell Division
168 rdf:type schema:DefinedTerm
169 N7ffeb53f21644e4da2c739d64f410024 rdf:first sg:person.01305166203.28
170 rdf:rest N110c41b3eb41438ab7f01586e574f1fd
171 N8b163d0ca85a4b33a92e6a70a5933d2d rdf:first sg:person.0626301614.27
172 rdf:rest Nb6c6b2d4e051485389a82a8047ea5df6
173 N9972f0565de74566addbda1e0ec2f6d1 schema:volumeNumber 18
174 rdf:type schema:PublicationVolume
175 Nae455434f55248dd96124628bc4085a1 rdf:first sg:person.013355461651.60
176 rdf:rest Nf5bf8afea8fb4ba1992e844c7ff9459c
177 Nafedb1d3947b4ae389cb712bd3f0f3d9 schema:name Springer Nature - SN SciGraph project
178 rdf:type schema:Organization
179 Nb6c6b2d4e051485389a82a8047ea5df6 rdf:first sg:person.01355254152.34
180 rdf:rest rdf:nil
181 Nc09e045094d0438baca0554b59063afc schema:name dimensions_id
182 schema:value pub.1011970400
183 rdf:type schema:PropertyValue
184 Nc89717951396402bb70dea36b29ffb2c schema:name pubmed_id
185 schema:value 10023661
186 rdf:type schema:PropertyValue
187 Nd11c948e43f14fbf9ecd7bb286468d90 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Down-Regulation
189 rdf:type schema:DefinedTerm
190 Ne07584b69f1e4e639187392961357ed7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Intestines
192 rdf:type schema:DefinedTerm
193 Ne5b9540a9e024248b746eb744e7d8cce schema:issueNumber 4
194 rdf:type schema:PublicationIssue
195 Nef447d0ada49433ab732172836b34fb3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
196 schema:name Animals
197 rdf:type schema:DefinedTerm
198 Nefdf3cb21e12468ea05b6193caef4c6e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
199 schema:name Cell Transformation, Neoplastic
200 rdf:type schema:DefinedTerm
201 Nf532df598e3e49fb951fe4e9c1afa441 rdf:first sg:person.01153613737.38
202 rdf:rest N8b163d0ca85a4b33a92e6a70a5933d2d
203 Nf5bf8afea8fb4ba1992e844c7ff9459c rdf:first sg:person.01235552457.39
204 rdf:rest N15f1ee5b2d044341a45530503a1c7e01
205 Nf7c31786ef9a4d6388791413cc1c5825 schema:name doi
206 schema:value 10.1038/sj.onc.1202397
207 rdf:type schema:PropertyValue
208 Nfc3ce6eae5d2423eb1d6b4a8b80f11ac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
209 schema:name Enzyme Induction
210 rdf:type schema:DefinedTerm
211 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
212 schema:name Medical and Health Sciences
213 rdf:type schema:DefinedTerm
214 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
215 schema:name Clinical Sciences
216 rdf:type schema:DefinedTerm
217 sg:grant.2408854 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.onc.1202397
218 rdf:type schema:MonetaryGrant
219 sg:grant.2438863 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.onc.1202397
220 rdf:type schema:MonetaryGrant
221 sg:grant.2472568 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.onc.1202397
222 rdf:type schema:MonetaryGrant
223 sg:grant.2495079 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.onc.1202397
224 rdf:type schema:MonetaryGrant
225 sg:grant.2495856 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.onc.1202397
226 rdf:type schema:MonetaryGrant
227 sg:journal.1097543 schema:issn 0950-9232
228 1476-5594
229 schema:name Oncogene
230 schema:publisher Springer Nature
231 rdf:type schema:Periodical
232 sg:person.01063521507.06 schema:affiliation grid-institutes:grid.412807.8
233 schema:familyName Shao
234 schema:givenName Jinyi
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01063521507.06
236 rdf:type schema:Person
237 sg:person.01153613737.38 schema:affiliation grid-institutes:grid.166341.7
238 schema:familyName Berger
239 schema:givenName David H
240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01153613737.38
241 rdf:type schema:Person
242 sg:person.01235552457.39 schema:affiliation grid-institutes:grid.166341.7
243 schema:familyName Albo
244 schema:givenName Daniel
245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235552457.39
246 rdf:type schema:Person
247 sg:person.01253543620.23 schema:affiliation grid-institutes:None
248 schema:familyName Isakson
249 schema:givenName Peter C
250 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01253543620.23
251 rdf:type schema:Person
252 sg:person.01305166203.28 schema:affiliation grid-institutes:grid.412807.8
253 schema:familyName Sheng
254 schema:givenName Hongmiao
255 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01305166203.28
256 rdf:type schema:Person
257 sg:person.01323503556.25 schema:affiliation grid-institutes:grid.166341.7
258 schema:familyName O'Mahony
259 schema:givenName Christine A
260 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01323503556.25
261 rdf:type schema:Person
262 sg:person.013355461651.60 schema:affiliation grid-institutes:grid.412807.8
263 schema:familyName Lamps
264 schema:givenName Laura
265 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013355461651.60
266 rdf:type schema:Person
267 sg:person.01355254152.34 schema:affiliation grid-institutes:grid.412807.8
268 schema:familyName Beauchamp
269 schema:givenName R Daniel
270 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01355254152.34
271 rdf:type schema:Person
272 sg:person.0626301614.27 schema:affiliation grid-institutes:grid.412807.8
273 schema:familyName DuBois
274 schema:givenName Raymond N
275 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0626301614.27
276 rdf:type schema:Person
277 sg:pub.10.1038/382386a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003505430
278 https://doi.org/10.1038/382386a0
279 rdf:type schema:CreativeWork
280 sg:pub.10.1038/383691a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031722017
281 https://doi.org/10.1038/383691a0
282 rdf:type schema:CreativeWork
283 sg:pub.10.1038/sj.onc.1201902 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000680860
284 https://doi.org/10.1038/sj.onc.1201902
285 rdf:type schema:CreativeWork
286 grid-institutes:None schema:alternateName 63198, USA
287 schema:name 63198, USA
288 Department of Inflammatory Disease Research, Searle R & D, St Louis, Missouri
289 rdf:type schema:Organization
290 grid-institutes:grid.166341.7 schema:alternateName Department of Surgery, Allegheny University of the Health Sciences, Philadelphia, Pennsylvania, USA
291 schema:name Department of Surgery, Allegheny University of the Health Sciences, Philadelphia, Pennsylvania, USA
292 rdf:type schema:Organization
293 grid-institutes:grid.412807.8 schema:alternateName Department of Cell Biology, The Vanderbilt Cancer Center, Vanderbilt University Medical Center, and VA Medical Center, 37232, Nashville, Tennessee, USA
294 Department of Medicine, The Vanderbilt Cancer Center, Vanderbilt University Medical Center, and VA Medical Center, 37232, Nashville, Tennessee, USA
295 Department of Pathology, The Vanderbilt Cancer Center, Vanderbilt University Medical Center, and VA Medical Center, 37232, Nashville, Tennessee, USA
296 Department of Surgery, The Vanderbilt Cancer Center, Vanderbilt University Medical Center, and VA Medical Center, 37232, Nashville, Tennessee, USA
297 schema:name Department of Cell Biology, The Vanderbilt Cancer Center, Vanderbilt University Medical Center, and VA Medical Center, 37232, Nashville, Tennessee, USA
298 Department of Medicine, The Vanderbilt Cancer Center, Vanderbilt University Medical Center, and VA Medical Center, 37232, Nashville, Tennessee, USA
299 Department of Pathology, The Vanderbilt Cancer Center, Vanderbilt University Medical Center, and VA Medical Center, 37232, Nashville, Tennessee, USA
300 Department of Surgery, The Vanderbilt Cancer Center, Vanderbilt University Medical Center, and VA Medical Center, 37232, Nashville, Tennessee, USA
301 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...